melatonin has been researched along with Atrial Fibrillation in 4 studies
Atrial Fibrillation: Abnormal cardiac rhythm that is characterized by rapid, uncoordinated firing of electrical impulses in the upper chambers of the heart (HEART ATRIA). In such case, blood cannot be effectively pumped into the lower chambers of the heart (HEART VENTRICLES). It is caused by abnormal impulse generation.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Angiotensin II (Ang II) induced Atrial fibrillation (AF) often accompanied with reduced ATRAP which is a negative modulator of Ang II type 1 receptor (AT1R)." | 8.12 | Melatonin inhibits angiotensin II-induced atrial fibrillation through preventing degradation of Ang II Type I Receptor-Associated Protein (ATRAP). ( Bi, HL; Liao, ZQ; Shen, TT; Shi, L; Su, ZL; Xia, YL; Xie, X; Zhang, Y, 2022) |
| "Melatonin is a hormone with anti-oxidant and anti-inflammatory properties in the cardiovascular system." | 7.01 | The Effects of Melatonin on the Oxidative Stress and Duration of Atrial Fibrillation after Coronary Artery Bypass Graft Surgery: A Randomized Controlled Trial. ( Ahmadi, ZH; Barati, S; Dastan, F; Jahangirifard, A; Tavakoli-Ardakani, M, 2021) |
| "Melatonin has been proven to have antiarrhythmic potential; however, several studies have recently challenged this view." | 5.91 | Melatonin increases susceptibility to atrial fibrillation in obesity via Akt signaling impairment in response to lipid overload. ( Fan, J; Fu, Y; Jiang, T; Liu, B; Liu, P; Qin, X; Zhang, Y; Zheng, Q, 2023) |
| "Melatonin treatment ameliorated BCAA-induced atrial damage and reversed BCAA-induced down-regulation of atrial PKGIα expression, CREB phosphorylation as well as KLF15 expression." | 5.72 | Activation of PKG-CREB-KLF15 by melatonin attenuates Angiotensin II-induced vulnerability to atrial fibrillation via enhancing branched-chain amino acids catabolism. ( Dong, X; Huang, YT; Luo, LY; Wang, HS; Wang, ZS; Xu, DY; Xu, YL; Xue, XD; Yu, LM; Zhao, JK; Zhao, QS; Zhou, ZJ, 2022) |
| "Angiotensin II (Ang II) induced Atrial fibrillation (AF) often accompanied with reduced ATRAP which is a negative modulator of Ang II type 1 receptor (AT1R)." | 4.12 | Melatonin inhibits angiotensin II-induced atrial fibrillation through preventing degradation of Ang II Type I Receptor-Associated Protein (ATRAP). ( Bi, HL; Liao, ZQ; Shen, TT; Shi, L; Su, ZL; Xia, YL; Xie, X; Zhang, Y, 2022) |
| "Melatonin is a hormone with anti-oxidant and anti-inflammatory properties in the cardiovascular system." | 3.01 | The Effects of Melatonin on the Oxidative Stress and Duration of Atrial Fibrillation after Coronary Artery Bypass Graft Surgery: A Randomized Controlled Trial. ( Ahmadi, ZH; Barati, S; Dastan, F; Jahangirifard, A; Tavakoli-Ardakani, M, 2021) |
| "Melatonin has been proven to have antiarrhythmic potential; however, several studies have recently challenged this view." | 1.91 | Melatonin increases susceptibility to atrial fibrillation in obesity via Akt signaling impairment in response to lipid overload. ( Fan, J; Fu, Y; Jiang, T; Liu, B; Liu, P; Qin, X; Zhang, Y; Zheng, Q, 2023) |
| "Melatonin treatment ameliorated BCAA-induced atrial damage and reversed BCAA-induced down-regulation of atrial PKGIα expression, CREB phosphorylation as well as KLF15 expression." | 1.72 | Activation of PKG-CREB-KLF15 by melatonin attenuates Angiotensin II-induced vulnerability to atrial fibrillation via enhancing branched-chain amino acids catabolism. ( Dong, X; Huang, YT; Luo, LY; Wang, HS; Wang, ZS; Xu, DY; Xu, YL; Xue, XD; Yu, LM; Zhao, JK; Zhao, QS; Zhou, ZJ, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 4 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yu, LM | 1 |
| Dong, X | 1 |
| Zhao, JK | 1 |
| Xu, YL | 1 |
| Xu, DY | 1 |
| Xue, XD | 1 |
| Zhou, ZJ | 1 |
| Huang, YT | 1 |
| Zhao, QS | 1 |
| Luo, LY | 1 |
| Wang, ZS | 1 |
| Wang, HS | 1 |
| Xie, X | 1 |
| Shen, TT | 1 |
| Bi, HL | 1 |
| Su, ZL | 1 |
| Liao, ZQ | 1 |
| Zhang, Y | 2 |
| Shi, L | 1 |
| Xia, YL | 1 |
| Qin, X | 1 |
| Fu, Y | 1 |
| Fan, J | 1 |
| Liu, B | 1 |
| Liu, P | 1 |
| Jiang, T | 1 |
| Zheng, Q | 1 |
| Barati, S | 1 |
| Jahangirifard, A | 1 |
| Ahmadi, ZH | 1 |
| Tavakoli-Ardakani, M | 1 |
| Dastan, F | 1 |
1 trial available for melatonin and Atrial Fibrillation
| Article | Year |
|---|---|
The Effects of Melatonin on the Oxidative Stress and Duration of Atrial Fibrillation after Coronary Artery Bypass Graft Surgery: A Randomized Controlled Trial.
Topics: Aged; Anti-Inflammatory Agents; Antioxidants; Atrial Fibrillation; Coronary Artery Bypass; Female; H | 2021 |
3 other studies available for melatonin and Atrial Fibrillation
| Article | Year |
|---|---|
Activation of PKG-CREB-KLF15 by melatonin attenuates Angiotensin II-induced vulnerability to atrial fibrillation via enhancing branched-chain amino acids catabolism.
Topics: Amino Acids, Branched-Chain; Angiotensin II; Atrial Fibrillation; Cyclic AMP Response Element-Bindin | 2022 |
Melatonin inhibits angiotensin II-induced atrial fibrillation through preventing degradation of Ang II Type I Receptor-Associated Protein (ATRAP).
Topics: Angiotensin II; Animals; Atrial Fibrillation; Melatonin; Mice; Proteasome Endopeptidase Complex; Rec | 2022 |
Melatonin increases susceptibility to atrial fibrillation in obesity via Akt signaling impairment in response to lipid overload.
Topics: Animals; Atrial Fibrillation; Insulin Resistance; Lipids; Melatonin; Mice; Mice, Obese; Obesity; Pro | 2023 |